Companies / Zura Bio Limited

Zura Bio Limited

Nasdaq: ZURACIK 1855644LA JOLLA, CA

Financials

Revenue
Net income$-68.65M
Total debt
Cash$205.13M
Diluted EPS$-1.06
Shares outstanding95.8M

Ownership

95.8M shares outstanding · as of Aug 11, 2026
4.0%10%+ / strategic
Ownership
10%+ / strategic3.98%3,815,930
Institutions49.00%46,952,146
Public float47.02%45,061,061

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Blavatnik Len10% owner
Eisner MarkDirector
Kulkarni Sandeep ChidambarCEOChief Executive Officer · Director
Nirula AjayDirector

Institutional holders 76

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 26, 2026AI Biotechnology LLC
10% owner
BuyClass A Ordinary Shares$12.50M+2.0M
+43.93%
6,552,725
6.84% of shares
high
Feb 21, 2026Nirula Ajay
Director
GrantShare Option (Right to Buy)+38K
37,812
0.04% of shares
low
Jan 23, 2026Thiara Parvinder
Director
GrantShare Option (Right to Buy)+39K
38,823
0.04% of shares
low
Jan 21, 2026Kulkarni Sandeep Chidambar
CEO
GrantEmployee Share Option (Right to Buy)+2.9M
2,934,107
3.06% of shares
low
Feb 21, 2026Eisner Mark
Director
GrantShare Option (Right to Buy)+38K
37,812
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Great Point Partners, LLCPassive13G/A3,815,930
Suvretta Capital Management, LLCPassive13G/A
Athanor CapitalPassive13G
Great Point Partners, LLCPassive13G/A4,215,930

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ZURAG9TY5A101